An organized set of primary and secondary sources covering clinical background, drug-safety signals, and patient-safety considerations.
FDA warning Tysabri Progressive Multifocal Leukoencephalopathy: Key Facts & Context โ detailed background and analysis.
Reference: Mayo Clinic โ Diseases & Conditions
Authoritative source for clinical, regulatory, and public-health background reading.
Reference: World Health Organization (WHO)
Authoritative source for clinical, regulatory, and public-health background reading.
Reference: European Medicines Agency (EMA)
Authoritative source for clinical, regulatory, and public-health background reading.